Experience

Stibbe advises on the equity offering of ProQR

Stibbe advises on the equity offering of ProQR

Stibbe advises on the equity offering of ProQR

10.09.2018 NL law

Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 

ProQR is a biopharmaceutical company creating transformative RNA medicines for the treatment of severe genetic rare diseases and listed on Nasdaq.

Team

Related experience

Our website uses functional cookies for the functioning of the website and analytic cookies that enable us to generate aggregated visitor data. We also use other cookies, such as third party tracking cookies - please indicate whether you agree to the use of these other cookies:

Privacy – en cookieverklaring